Aorta


Endovascular treatment of a primary aortoduodenal fistula.
De Smet A, Van den Eynde W, Peeters P, Verbist J.
J Cardiovasc Surg (Torino). 2018 Dec;59(6):844-845.

First implant takes place in Bolton Medical's Treo Registry at Imelda Hospital Bonheiden.

A Growing Type I Thoraco-abominal Aneurysm after treatment with a Multilayer stent.
Van den Eynde W, Verbist J. 
Eur J Vasc Endovasc Surg. 2017 Jun 29

Endovascular repair of a type 1a endoleak after Ch-EVAR with a b-EVAR. 
Van den Eynde W, Van Breussegem A, Joos B, Keirse K, Verbist J, Peeters P.
Cardiovasc Intervent Radiol. 2016 Sep;39(9):1361-3.

Early Results from the ENGAGE Registry: Real-world Performance of the Endurant Stent Graft for Endovascular AAA Repair in 1262 Patients. 
Stokmans RA1Teijink JAForbes TLBöckler DPeeters PRiambau VHayes PDvan Sambeek MR.
Eur J Vasc Endovasc Surg. 2012 Oct;44(4):369-75. doi: 10.1016/j.ejvs.2012.07.005. Epub 2012 Jul 24.

Aorto-iliac stent graft infection complicated by endotension and consequent rupture of the aneurysmal sac: a case report.
Van den Eynde W, van Riel W, Nevelsteen A, Daenen G.
Acta Chir Belg. 2011 Jul-Aug;111(4):246-9.

Treatment of a left common iliac aneurysm with endovascular Powerlink stentgraft in a patient with an occlusion of a left common iliac stent.
Libeer F, Peeters PVerbist J.
Acta Chir Belg. 2009 Nov-Dec;109(6):785-7.

Technical Challenges and Solutions for the Endovascular Treatment of a Complex Aortoiliac Occlusive Disease.
Bosiers M, Deloose K, Verbist J, Peeters P.
Endovascular Management of Aorto-iliac Complications 2008.

Complex thoracic aortic aneurysm: a combined open and endovascular approach.
Wolthuis AM, Houthoofd S, Deferm H, Haenen L, Verbist JPeeters P.
Acta Chir Belg. 2005 Aug;105(4):400-2.

EVAR Patients with Challenging Iliac Arteries.
Peeters P, Bosiers M, Verbist J, Deloose K.
Endovascular Today 2003 May/June; Supplement 16-19.

Anatomical Criteria for Endovascular Abdominal Aortic Aneurysm Repair.
Peeters P, Bosiers M, Verbist J.
Journal Des Maladies Vasculaires. Vol 27, suppl 1, IS40, March 2002.

Two Year European Experience using a uni-body device (Endologix) for Endovascular AAA Exclusion.
Peeters P, Bosiers M, Verbist J, Deferm H, Haenen L, Vermaercke M, De Waele J, Deloose K.
Endocardiovascular WEB magazine. Vol 6, 2, June2002.

Endoleaks after endoluminal repair of abdominal aortic aneurysms: diagnosis and treatment.
Verbist JPeeters P, Bosiers M, Deferm H, Haenen L, Vermaercke M, Vercaeren P.
Acta Chir Belg. 2001 Jul-Aug;101(4):149-54.

Succesful treatment of secondary aorto-esophageal fistula by use of silver impregnated aortic prosthesis and omental pedicle graft.
Keirse K, Peeters P, Verbist J, Bosiers M, Deloose K.
Journal of Cardiovasc Surgery 2003; 44: 43.

 

Carotiden en supra-aortische bloedvaten


Spontaneous rupture of an aneurysm of the right subclavian artery as a first presentation of Ehlers Danlos syndrome in a 15-year old boy.
Verbert A, Verbist JPeeters P, Deferm H, Haenen L.
Acta Chir Belg. 2013 Sep-Oct;113(5):367-72.

Dysphagia lusoria. Indications and surgical approaches for non-aneurysmatic aberrant right subclavian artery. 
Debonnaire G, Verbist J, Peeters P. 
Acta Chir Belg. 2012 May-Jun;112(3):237-9.

The role of carotid artery stenting for recent cerebral ischemia.
Bosiers M, Callaert J, Deloose K, Verbist J, Keirse K, Peeters P.
J Cardiovasc Surg (Torino). 2010 Jun;51(3):293-304.

Carotid stenting is a valuable alternative to carotid endarterectomy.
Bosiers M, Deloose K, Verbist JPeeters P.
J Cardiovasc Surg (Torino). 2008 Dec;49(6):709-19.

What practical factors guide the choice of stent and protection device during carotid angioplasty?
Bosiers M, Deloose K, Verbist JPeeters P.
Eur J Vasc Endovasc Surg. 2008 Jun;35(6):637-43.

The impact of embolic protection device and stent design on the outcome of CAS.
Bosiers M, Deloose K, Verbist J, Peeters P.
Perspect Vasc Surg Endovasc Ther. 2008 Sep;20(3):272-9.

What practical factors guide the choice of stent and protection device during carotid angioplasty?
Bosiers M, Deloose K, Peeters P, Verbist J.
Eur J Vasc Endovasc Surg. 2008 Jun;35(6):637-43.

Does free cell area influence the outcome in carotid artery stenting?
Bosiers M, de Donato G, Deloose K, Verbist JPeeters P, Castriota F, Cremonesi A, Setacci C.
Eur J Vasc Endovasc Surg. 2007 Feb;33(2):135-41

Do device characteristics impact outcome in carotid artery stenting?
Hart JP, Peeters PVerbist J, Deloose K, Bosiers M.
J Vasc Surg. 2006 Oct;44(4):725-30.

Review of stents for the carotid artery.
Bosiers M, Deloose K, Verbist J, Peeters P.
J Cardiovasc Surg (Torino). 2006 Apr;47(2):107-13.

Carotid artery stenting: which stent for which lesion?
Bosiers M, Deloose K, Verbist JPeeters P.
Vascular. 2005 Jul-Aug;13(4):205-10.

Does carotid artery stenting work on the long run: 5-year results in high-volume centers (ELOCAS Registry).
Bosiers M, Peeters P, Deloose K, Verbist J, Sievert H, Sugita J, Castriota F, Cremonesi A.
J Cardiovasc Surg (Torino). 2005 Jun;46(3):241-7.

Endovascular treatment strategies for supra-aortic arterial occlusive disease.
Peeters PVerbist J, Deloose K, Bosiers M.
J Cardiovasc Surg (Torino). 2005 Jun;46(3):193-200.

Selection of treatment for patients with carotid artery disease: medication, carotid endarterectomy, or carotid artery stenting.
Bosiers M, Peeters P, Deloose K, Verbist J, Sprouse RL 2nd.
Vascular. 2005 Mar-Apr;13(2):92-7.

Choice of protection devices in carotid angioplasty. Two case reports.
Hendrickx T, Verbist JPeeters P.
Acta Chir Belg. 2004 Jun;104(3):357-60.

 

Perifere bloedvaten


BeGraft Peripheral PMCF Study: 12-month results.
Deloose KBosiers MCallaert JPeeters P, Verbist J, van den Eynde WMaene LBeelen RKeirse K.
J Cardiovasc Surg (Torino). 2017 May 26

24-Month Data from the Bravissimo: A Large-scale Prospective Registry on iliac Stenting for TASC A & B and TASC C & D Lesions.
de Donato G, Bosiers M, Setacci F, Deloose K, Galzerano G, Verbist J, Peeters P, Setacci C.
Ann Vasc Surg. 2015;29(4):738-50

IVUS is not worth the cost for peripheral arterial disease interventions.
D Struyve, W Van den Eynde, J Verbist, P Peeters.
CX 14 Vascular and endovascular Challenges Update, Apr 2015.

Primary stenting is nowadays the golden standard treatment for TASC II A & B iliac lesions: The definitive MISAGO 1-year results.
Deloose K, Bosiers M, Callaert J, Verbist J, Vermassen F, Scheinert D, Torsello G, Peeters P.
J Cardiovasc Surg (Torino). 2014 Oct 21.

Popliteal artery aneurysm: when open, when endo? 
Gallala S, Verbist J, Van den Eynde W, Peeters P.
J Cardiovasc Surg (Torino). 2014 Apr;55(2 Suppl 1):239-47

Which is currently the best strategy for treatment of SFA in-stent restenosis? 
Elens M, Verbist J, Keirse K, Van den Eynde W, Peeters P.
J Cardiovasc Surg (Torino). 2014 Aug;55(4):477-81.

Refining stent technologies for femoral interventions
Bosiers M, Deloose K, Callaert J, Maene L, Keirse K, Verbist J, Peeters P.
J Cardiovasc Surg (Torino). 2012 Aug;53(4):465-73.

Endovascular procedures and new insights in diabetic limb salvage.
Peeters PVerbist J, Keirse K, Callaert J, Deloose K, Bosiers M.
J Cardiovasc Surg (Torino). 2012 Feb;53(1):31-7.

Results of the Protégé Everflex 200 mm long nitinol stent (ev3) in TASC C and D femoropopliteal lesions. 
Bosiers M, Deloose K, Callaert J, Moreels N, Keirse K, Verbist J, Peeters P.
J Vasc Surg. 2011 Oct;54(4):1042-50.

Drug eluting stents below the knee. 
Bosiers M, Deloose K, Callaert J, Keirse K, Verbist J, Peeters P.
J Cardiovasc Surg (Torino). 2011 Apr;52(2):231-4

Prevention and treatment of in-stent restenosis.
Bosiers M, Deloose K, Keirs K, Verbist JPeeters P.
J Cardiovasc Surg (Torino). 2010 Aug;51(4):591-8.

Endovascular management of acute limb ischemia.
Peeters PVerbist J, Keirse K, Deloose K, Bosiers M.
J Cardiovasc Surg (Torino). 2010 Jun;51(3):329-36.

Are drug-eluting stents the future of SFA treatment?
Bosiers M, Deloose K, Keirse K, Verbist JPeeters P.
J Cardiovasc Surg (Torino). 2010 Feb;51(1):115-9.

What is involved in offering an acute endovascular service?
Patrick Peeters, MD, Ozan Yazar, MD, Wouter Van den Eynde, MD, Jürgen Verbist, MD, Koen De Loose, MD, Marc Bosiers, MD.
Vascular and Endovascular Controversies Update, Charing Cross, 2010

Other endovascular methods of treating the diabetic foot.
Peeters P, Keirse K, Verbist J, Deloose K, Bosiers M.
J Cardiovasc Surg (Torino). 2009 Jun;50(3):313-21.

Update management below knee intervention.
Bosiers M, Deloose K, Verbist JPeeters P.
Minerva Cardioangiol. 2009 Feb;57(1):117-29.

Present and future of endovascular SFA treatment: stents, stent-grafts, drug coated balloons and drug coated stents.
Bosiers M, Deloose K, Verbist JPeeters P.
J Cardiovasc Surg (Torino). 2008 Apr;49(2):159-65.

Will heparin-bonded PTFE replace autologous venous conduits in infrapopleal bypass?
Peeters P, Verbist J, Bosiers M, Deloose K.
Italian Journal of Vascular and Endovascular Surgery 15(3):143-148 September 2008.

Results with heparin bonded polytetrafluoroethylene grafts for femorodistal bypasses.
Peeters PVerbist J, Deloose K, Bosiers M.
J Cardiovasc Surg (Torino). 2006 Aug;47(4):407-13.

Endovascular therapy as the primary approach for limb salvage in patients with critical limb ischemia: experience with 443 infrapopliteal procedures.
Bosiers M, Hart JP, Deloose K, Verbist J, Peeters P.
Vascular. 2006 Mar-Apr;14(2):63-9.

Will absorbable metal stent technology change our practice?
Bosiers M, Deloose K, Verbist J, Peeters P.
J Cardiovasc Surg (Torino). 2006 Aug;47(4):393-7.

Percutaneous transluminal angioplasty for treatment of ''below-the-knee'' critical limb ischemia: early outcomes following the use of sirolimus-eluting stents.
Bosiers M, Deloose K, Verbist J, Peeters P.
J Cardiovasc Surg (Torino). 2006 Apr;47(2):171-6.

Preliminary results after application of absorbable metal stents in patients with critical limb ischemia.
Peeters P, Bosiers M, Verbist J, Deloose K, Heublein B.
J Endovasc Ther. 2005 Feb;12(1):1-5.

 

Veneus


Right sided Cockett's Syndrome.
 
Du Pont B, Verbist J, Van den Eynde W, Peeters P.
Acta Chir Belg. 2016 Apr;116(2):114-8.

 

design: joumani.be

Comments